Immunological features and efficacy of the reconstructed epitope vaccine CtUBE against Helicobacter pylori infection in BALB/c mice model

Applied Microbiology and Biotechnology

Volumn 97, Issue 6, 2013, Pages 2367-2378

  Guo, Le ^a,b   Liu, Kunmei ^a,b   Zhao, Wenfeng ^b   Li, Xiaokang ^b   Li, Tong ^b   Tang, Feng ^b   Zhang, Rui ^b   Wu, Wutong ^b   Xi, Tao ^b  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cholera toxin B subunit; Epitope vaccine; Helicobacter pylori; Neutralizing antibody; Urease B subunit

Indexed keywords

CHOLERA TOXIN B SUBUNIT; ENZYMATIC ACTIVITIES; HELICOBACTER PYLORI; HELICOBACTER PYLORI INFECTIONS; INHIBITORY EFFECT; NEUTRALIZING ANTIBODIES; THERAPEUTIC EFFICACY; UREASE B SUBUNIT;

ANTIBODIES; ENZYME INHIBITION; IMMUNIZATION; MAMMALS; PURIFICATION; VACCINES;

EPITOPES;

CHOLERA TOXIN B SUBUNIT; EPITOPE; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; UREASE;

ANTIBODY; BACTERIUM; CHOLERA; COLONIZATION; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOASSAY; INFECTIOUS DISEASE; PROTEIN; RODENT; VACCINATION; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNIZATION; IMMUNOGENICITY; MALE; MOUSE; NONHUMAN;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, NEUTRALIZING; BACTERIAL VACCINES; CHOLERA TOXIN; DISEASE MODELS, ANIMAL; EPITOPES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNITY, MUCOSAL; MICE; MICE, INBRED BALB C; RECOMBINANT FUSION PROTEINS; SERUM; UREASE; VACCINES, SYNTHETIC; VIRULENCE FACTORS;

HELICOBACTER PYLORI; MUS;

EID: 84878847623     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-012-4486-1     Document Type: Article

References (40)

1. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383(6603):787-793
2. Areas AP, Oliveira ML, Miyaji EN, Leite LC, Aires KA, Dias WO, Ho PL (2004) Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice. Biochem Biophys Res Commun 321(1):192-196
3. Cheng H, Hu FL (2005) [The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing]. Zhonghua Yi Xue Za Zhi 85(39):2754-2757
4. Czinn SJ, Blanchard T (2011) Vaccinating against Helicobacter pylori infection. Nat Rev Gastroenterol Hepatol 8(3):133-140
5. DeLyria ES, Redline RW, Blanchard TG (2009) Vaccination of mice against H. pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 136(1):247-256
6. DeLyria ES, Nedrud JG, Ernst PB, Alam MS, Redline RW, Ding H, Czinn SJ, Xu J, Blanchard TG (2011) Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A. Helicobacter 16(3):169-178
7. Eaton KA, Brooks CL, Morgan DR, Krakowka S (1991) Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 59(7):2470-2475
8. Ermak TH, Giannasca PJ, Nichols R, Myers GA, Nedrud J, Weltzin R, Lee CK, Kleanthous H, Monath TP (1998) Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 188(12):2277-2288
9. Ferrero RL, Thiberge JM, Huerre M, Labigne A (1998) Immune responses of specific-pathogen-free mice to chronic Helicobacter pylori (strain SS1) infection. Infect Immun 66(4):1349-1355
10. Gomez-Duarte OG, Lucas B, Yan ZX, Panthel K, Haas R, Meyer TF (1998) Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 16(5):460-471
11. Graham DY, Malaty HM, Evans DG, Evans DJ Jr, Klein PD, Adam E (1991) Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology 100(6):1495-1501
12. Guo L, Li X, Tang F, He Y, Xing Y, Deng X, Xi T (2012a) Immunological features and the ability of inhibitory effects on enzymatic activity of an epitope vaccine composed of cholera toxin B subunit and B cell epitope from Helicobacter pylori urease A subunit. Appl Microbiol Biotechnol 93(5):1937-1945
13. Guo L, Liu K, Xu G, Li X, Tu J, Tang F, Xing Y, Xi T (2012b) Prophylactic and therapeutic efficacy of the epitope vaccine CTB-UA against Helicobacter pylori infection in a BALB/c mice model. Appl Microbiol Biotechnol 95(6):1437-1444
14. Guy B, Hessler C, Fourage S, Haensler J, Vialon-Lafay E, Rokbi B, Millet MJ (1998) Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 16(8):850-856
15. Harakuni T, Sugawa H, Komesu A, Tadano M, Arakawa T (2005) Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems. Infect Immun 73(9):5654-5665
16. Hirai Y, Hayashi S, Shimomura H, Oguma K, Yokota K (1999) Association of Helicobacter pylori with gastroduodenal diseases. Jpn J Infect Dis 52(5):183-197
17. Hirota K, Nagata K, Norose Y, Futagami S, Nakagawa Y, Senpuku H, Kobayashi M, Takahashi H (2001) Identification of an antigenic epitope in Helicobacter pylori urease that induces neutralizing antibody production. Infect Immun 69(11):6597-6603
18. Khan MK, Bemana M (2012) Association of Helicobacter pylori infection and gastric carcinoma. Mymensingh Med J 21(1):80-84
19. Kovacs-Nolan J, Mine Y (2006) Tandem copies of a human rotavirus VP8 epitope can induce specific neutralizing antibodies in BALB/c mice. Biochim Biophys Acta 1760(12):1884-1893
20. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF (1997) A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112(4):1386-1397
21. Liu KY, Shi Y, Luo P, Yu S, Chen L, Zhao Z, Mao XH, Guo G, Wu C, Zou QM (2011) Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. Vaccine 29(38):6679-6685
22. Losonsky GA, Kotloff KL, Walker RI (2003) B cell responses in gastric antrum and duodenum following oral inactivated Helicobacter pylori whole cell (HWC) vaccine and LT(R192G) in H. pylori seronegative individuals. Vaccine 21(5-6):562-565
23. Maeda K, Yamashiro T, Minoura T, Fujioka T, Nasu M, Nishizono A (2002) Evaluation of therapeutic efficacy of adjuvant Helicobacter pylori whole cell sonicate in mice with chronic H. pylori infection. Microbiol Immunol 46(9):613-620
24. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1(8390):1311-1315
25. Marshall BJ, Barrett LJ, Prakash C, McCallum RW, Guerrant RL (1990) Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology 99(3):697-702
26. Miyashita M, Joh T, Watanabe K, Todoroki I, Seno K, Ohara H, Nomura T, Miyata M, Kasugai K, Tochikubo K, Itoh M, Nitta M (2002) Immune responses in mice to intranasal and intracutaneous administration of a DNA vaccine encoding Helicobacter pylori-catalase. Vaccine 20(17-18):2336-2342
27. Mohammadi M, Nedrud J, Redline R, Lycke N, Czinn SJ (1997) Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113(6):1848-1857
28. Nagata K, Mizuta T, Tonokatu Y, Fukuda Y, Okamura H, Hayashi T, Shimoyama T, Tamura T (1992) Monoclonal antibodies against the native urease of Helicobacter pylori: synergistic inhibition of urease activity by monoclonal antibody combinations. Infect Immun 60(11):4826-4831
29. Nystrom J, Raghavan S, Svennerholm AM (2006) Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect 8(2):442-449
30. Qiu Y, Wang YC, Tao HX, Zhan DW, Yuan SL, Wang P, Wang LC, Han XP, Li CS, Li JK, Liu CJ (2010) Identification of B-cell epitopes in urease B subunit of Helicobacter pylori bound by neutralizing antibodies. Vaccine 28(32):5220-5227
31. Romagnani S (1999) Th1/Th2 cells. Inflamm Bowel Dis 5(4):285-294
32. Sack RB, Gyr K (1994) Helicobacter pylori infections in the developing world. Summary of a workshop organized at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR, B) from February 2 to 4, 1993. J Diarrhoeal Dis Res 12(2):144-145
33. Sadeghi H, Bregenholt S, Wegmann D, Petersen JS, Holmgren J, Lebens M (2002) Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo. Immunology 106(2):237-245
34. + T cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk. J Immunol 182(11):7085-7101
35. Sette A, Keogh E, Ishioka G, Sidney J, Tangri S, Livingston B, McKinney D, Newman M, Chesnut R, Fikes J (2002) Epitope identification and vaccine design for cancer immunotherapy. Curr Opin Investig Drugs 3(1):132-139
36. Sijun H, Yong X (2009) Helicobacter pylori vaccine: mucosal adjuvant and delivery systems. Indian J Med Res 130(2):115-124
37. Todoroki I, Joh T, Watanabe K, Miyashita M, Seno K, Nomura T, Ohara H, Yokoyama Y, Tochikubo K, Itoh M (2000) Suppressive effects of DNA vaccines encoding heat shock protein on Helicobacter pylori-induced gastritis in mice. Biochem Biophys Res Commun 277(1):159-163
38. Tsimmerman IS (2009) [Gastroduodenal diseases and Helicobacter pylori infection: overview]. Klin Med (Mosk) 87(5):9-15
39. Zhao W, Wu W, Xu X (2007) Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice. Vaccine 25(44):7664-7673
40. Zhou WY, Shi Y, Wu C, Zhang WJ, Mao XH, Guo G, Li HX, Zou QM (2009) Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. Vaccine 27(36):5013-5019